Author:
Cho Ig Jun,Lee Chang Woo,Lee Myeong Youl,Kang Moo Rim,Yun Jieun,Oh Soo Jin,Han Sang-Bae,Lee Kiho,Park Song-Kyu,Kim Hwan Mook,Jung Sang-Hun,Kang Jong Soon
Funder
Korea Health Technology R&D Project
Ministry of Health, Welfare & Family Affairs, Republic of Korea
KRIBB Research Initiative Program
Subject
Pharmacology,Immunology,Immunology and Allergy
Reference17 articles.
1. Zaltoprofen inhibits bradykinin-induced responses by blocking the activation of second messenger signaling cascades in rat dorsal root ganglion cells;Tang;Neuropharmacology,2005
2. Preemptive analgesia by zaltoprofen that inhibits bradykinin action and cyclooxygenase in a post-operative pain model;Muratani;Neurosci Res,2005
3. NSAID zaltoprofen possesses novel anti-nociceptive mechanism through blockage of B2-type bradykinin receptor in nerve endings;Matsumoto;Neurosci Lett,2006
4. Zaltoprofen, a non-steroidal anti-inflammatory drug, inhibits bradykinin-induced pain responses without blocking bradykinin receptors;Hirate;Neurosci Res,2006
5. Effect of a novel anti-inflammatory drug, 2-(10, 11-dihydro-10-oxo-dibenzo [b, f]-thiepin-2-yl)propionic acid (CN-100), on the proteoglycan biosynthesis in articular chondrocytes and prostaglandin E2 production in synovial fibroblasts;Ito;Res Commun Chem Pathol Pharmacol,1990
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献